Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

BDTXBDTX
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in BLACK DIAMOND THERAPEUTICS I

GOLDMAN SACHS GROUP INC holds 288,780 shares of BDTX (BLACK DIAMOND THERAPEUTICS I), worth $534,243 as of 2026-Q2. The position was decreased (-57.8% shares).

Current Value

$534,243

Current Shares

288,780

Total Value Change

-$501,166

Total Shares Change

-195,056

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
288,780
-57.8%
$534,2430.0%$1.85
0
2026-Q1
Increased
684,418
+110.4%
$1.5M0.0%$2.30
41
2025-Q4
Decreased
325,327
-27.6%
$790,5450.0%$2.49
0
2025-Q3
Increased
449,018
+28.1%
$1.7M0.0%$3.73
32
2025-Q2
Decreased
350,644
-26.9%
$869,5970.0%$2.35
0
2025-Q1
Decreased
479,387
-0.9%
$743,0500.0%$1.61
0
2024-Q4
New
483,836
-
$1M0.0%$2.15
35

Other major holders of BDTX: RA CAPITAL MANAGEMENT, L.P.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used